Enzo Biochem, Inc.
ENZB · OTC
7/31/2024 | 7/31/2023 | 7/31/2022 | 7/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 2.7% | -71% | -9.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 45.9% | 37.2% | 39.2% | 45.5% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -26.2% | -71.9% | -14% | 2.8% |
| Net Income | -$0 | $0 | -$0 | $0 |
| % Margin | -81.7% | 65.3% | -21.1% | 2.9% |
| EPS Diluted | -0.51 | -1.27 | -0.46 | 0.071 |
| % Growth | 59.8% | -176.1% | -748.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |